Publications

Detailed Information

The efficacy and safety of acupuncture for cerebral vasospasm after subarachnoid hemorrhage: study protocol for a randomized controlled trial

DC Field Value Language
dc.contributor.authorCho, Seung-Yeon-
dc.contributor.authorLee, Dong-Hyuk-
dc.contributor.authorShin, Hee Sup-
dc.contributor.authorLee, Seung Hwan-
dc.contributor.authorKoh, Jun Seok-
dc.contributor.authorJung, Woo-Sang-
dc.contributor.authorMoon, Sang-Kwan-
dc.contributor.authorPark, Jung-Mi-
dc.contributor.authorKo, Chang-Nam-
dc.contributor.authorKim, Ho-
dc.contributor.authorPark, Seong-Uk-
dc.date.accessioned2017-03-20T06:31:54Z-
dc.date.available2017-03-20T16:01:48Z-
dc.date.issued2015-02-28-
dc.identifier.citationTrials, 16(1):68ko_KR
dc.identifier.urihttps://hdl.handle.net/10371/109867-
dc.description.abstractBackground
Subarachnoid hemorrhage (SAH) is a neurological disease with a high mortality rate. Several serious complications frequently arise after successful surgery for this condition. Cerebral vasospasm, one such complication, occurs in 50 to 70% of SAH patients. These patients suffer neurological symptoms known as delayed ischemic neurological deficit (DIND); however, the effect of treatment of vasospasm is limited. The major pathogenesis of cerebral vasospasm is the reduction of nitric oxide (NO) and activation of vasoconstrictors. Acupuncture is known to increase the production and activity of vascular endothelial cell-derived NO and improve endothelium-dependent vasodilatation. A preliminary retrospective case study to investigate the ability of acupuncture to prevent the occurrence of cerebral vasospasm has been conducted. However, no randomized, controlled clinical trials have been carried out to evaluate the efficacy of acupuncture for cerebral vasospasm.

Methods/Design
This trial will be a single-center, randomized, placebo-controlled, parallel group, patient-assessor-blinded clinical trial. A total of 80 patients with SAH will be randomized into two groups: a study group given acupuncture, electroacupuncture, and intradermal acupuncture, and a control group given mock transcutaneous electrical nerve stimulation and sham intradermal acupuncture. Intervention will start within 96 h after SAH, and a total of 12 sessions will be performed during a 2-week period. The primary outcome measure will be the occurrence of DIND, and the secondary outcomes will be vasospasm as measured by cerebral angiography, transcranial Doppler, clinical symptoms, vasospasm-related infarcts, NO and endothelin-1 plasma levels, mortality, and modified Rankin Scale scores.

Discussion
This trial will examine the efficacy and safety of acupuncture for cerebral vasospasm after SAH. The placebo effect will be excluded and the mechanism of action of the treatments will be evaluated through blood testing.

Trial registration
ClinicalTrials.gov NCT0227594, Registration date: 26 October 2014.
ko_KR
dc.language.isoenko_KR
dc.publisherBioMed Centralko_KR
dc.subjectSubarachnoid hemorrhageko_KR
dc.subjectVasospasmko_KR
dc.subjectDelayed ischemic neurological deficitko_KR
dc.subjectAcupunctureko_KR
dc.titleThe efficacy and safety of acupuncture for cerebral vasospasm after subarachnoid hemorrhage: study protocol for a randomized controlled trialko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor조승연-
dc.contributor.AlternativeAuthor이동혁-
dc.contributor.AlternativeAuthor신희섭-
dc.contributor.AlternativeAuthor이승환-
dc.contributor.AlternativeAuthor고준석-
dc.contributor.AlternativeAuthor정우상-
dc.contributor.AlternativeAuthor문상관-
dc.contributor.AlternativeAuthor박정미-
dc.contributor.AlternativeAuthor고창남-
dc.contributor.AlternativeAuthor김호-
dc.contributor.AlternativeAuthor박성욱-
dc.language.rfc3066en-
dc.rights.holderCho et al.; licensee BioMed Central.-
dc.date.updated2017-01-06T10:42:34Z-
Appears in Collections:
Files in This Item:

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share